Why is Venmax Drugs falling/rising?

As of 15-Sep, Venmax Drugs & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 26.05, reflecting a decrease of Rs 1.31 or 4.79%. Today's price summary indicates that the stock has underperformed its sector by 4.34% and has fallen after two consecutive days of gains. It opened with a significant loss of 4.97% and reached an intraday low of Rs 26. Additionally, the stock's delivery volume has decreased by 18.45% compared to the 5-day average, suggesting a drop in investor participation. The stock's performance over the past week shows an increase of 8.54%, but it has declined by 8.63% over the past month, indicating volatility in its recent performance.
Broader market context reveals that while Venmax has had a year-to-date return of 44.40%, significantly outperforming the Sensex's 4.67%, its recent struggles are notable. The stock's current decline contrasts with the Sensex's modest gain of 1.24% over the past week. This divergence suggests that while the broader market remains stable, Venmax is facing specific challenges that are impacting its price negatively, including the recent trend reversal and reduced trading activity.